May 29, 2019 / 1:42 PM / 3 months ago

BRIEF-Health Canada Approves Tecentriq Combo Therapy For First-Line Treatment Of Metastatic Non-Squamous Non-Small Cell Lung Cancer

May 29 (Reuters) - Roche Holding AG:

* HEALTH CANADA APPROVES TECENTRIQ® (ATEZOLIZUMAB) COMBINATION THERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below